Logo - springer
Slogan - springer

| High Blood Pressure & Cardiovascular Prevention – incl. option to publish open access

High Blood Pressure & Cardiovascular Prevention

High Blood Pressure & Cardiovascular Prevention

Editor-in-Chief: Massimo Volpe

ISSN: 1120-9879 (print version)
ISSN: 1179-1985 (electronic version)

Journal no. 40292

$171.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 4 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Top-15 most downloaded articles | READ for FREE through November 17, 2018

Which Target Blood Pressure in Year 2018? Evidence from Recent Clinical Trials 

Sondre Heimark, Julian E. Mariampillai, Krzysztof Narkiewicz, Peter M. Nilsson, Sverre E. Kjeldsen

Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk 

Enrico Agabiti Rosei, Massimo Salvetti

Arterial Stiffness and Vascular Aging: From Pathophysiology to Treatment, with a Look at the Future 

Agostino Virdis

Juxtaglomerular Cell Phenotypic Plasticity 

Alexandre Góes Martini, A. H. Jan Danser

The Role of Renin–Angiotensin–Aldosterone System and Its New Components in Arterial Stiffness and Vascular Aging 

Mario Fritsch Neves, Ana Rosa Cunha, Michelle Rabello Cunha, Ronaldo Altenburg Gismondi, Wille Oigman

Proprotein Convertase Subtilisin-Kexin Type 9 (PCSK9) Inhibitors and Cardiovascular Risk: Does a Further Analysis of the Fourier Trial Suggest Changes in the Target of Lipid Lowering Therapy? 

Nazzareno Cervelli, Giuliano Tocci, Claudio Ferri

Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform 

Massimo Volpe, Giuliano Tocci, Alejandro de la Sierra, Reinhold Kreutz, Stéphane Laurent, Athanasios J. Manolis, Kostantinos Tsioufis

Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product 

Arrigo Francesco Giuseppe Cicero, Federica Fogacci, Martino Morbini, Alessandro Colletti, Marilisa Bove, Maddalena Veronesi, Marina Giovannini, Claudio Borghi

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 

Giuliano Tocci, Giovambattista Desideri, Elisa Roca, Calogero Calcullo, Massimo Crippa, Nicola De Luca, Giovanni Vincenzo Gaudio, Laura Maria Lonati, Leo Orselli, Angelo Scuteri, Vito Vulpis, Benedetto Acone, Augusto Zaninelli, on behalf of the THYPERevolution Steering Committee

Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines 

Christina Antza, Ioannis Doundoulakis, Stella Stabouli, Vasilios Kotsis

Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk 

Riccardo Sarzani, Francesco Spannella, Federico Giulietti, Paolo Balietti, Guido Cocci, Marica Bordicchia

Calcium Channel Blockers for the Clinical Management of Hypertension 

Time Trend Analysis of Hypertension Prevalence, Awareness, Treatment and Control in Italy: Novel Insights from Recent National Surveys in the General Population 

Cushing’s Syndrome: Screening and Diagnosis 

Read this Journal on Springerlink

For authors and editors

  • Aims and Scope

    Aims and Scope


    High Blood Pressure & Cardiovascular Prevention promotes knowledge, update and discussion in the field of hypertension and cardiovascular disease prevention, by providing a regular programme of independent review articles covering key aspects of the management of hypertension and cardiovascular diseases. The journal includes:  

    • Invited 'State of the Art' reviews. 
    • Expert commentaries on guidelines, major trials, technical advances.
    • Presentation of new intervention trials design.
    • 'Pros and Cons' or round tables on controversial issues.
    • Statements on guidelines from hypertension and cardiovascular scientific societies.
    • Socio-economic issues.
    • Cost/benefit in prevention of cardiovascular diseases.
    • Monitoring of healthcare systems.
    • News and views from the Italian Society of Hypertension (including abstracts).

    All manuscripts are subject to peer review by international experts. Letters to the editor are welcomed and will be considered for publication.               

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer International Publishing Switzerland

Alerts for this journal


Get the table of contents of every new issue published in High Blood Pressure & Cardiovascular Prevention.

Additional information